Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol. 2010;125(2):126-37.
Bernard Y-H Thong, Teck-Choon Tan. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71(5): 684-700.
DuongTA, Valeyrie-AllanoreL, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017;390(10106):1996-2011.
Rieder M. Adverse Drug Reactions Across the Age Continuum: Epidemiology, Diagnostic Challenges, Prevention, and Treatments. J Clin Pharmacol. 2018;58(S10):36-47.
Doña I, Barrionuevo E, Blanca-Lopez N, Torres MJ, Fernandez TD, Mayorga C. et al. Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity. J Investig Allergol Clin Immunol. 2014;24(3):143-53.
Sachs B, Dubrall D, Fischer-Barth W, Schmid M, Stingl J. Drug-induced anaphylactic reactions in children: A retrospective analysis of 159 validated spontaneous reports. Pharmacoepidemiol Drug Saf. 2019. doi: 10.1002/pds.4726.
Minjon L, van den Ban E, de Jong E, Souverein PC, Egberts TCG, Heerdink ER. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics. J Child Adolesc Psychopharmacol. 2019. doi: 10.1089/cap.2018.0139.
Balabolkin I.I. Drug allergy in children: clinical and pathogenetic types, diagnosis and prevention. Rossiyskiy pediatricheskiy zhurnal. 2011; 1: 49-53.
Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol. 2012;68(5):801-10.
Eliseeva T, Tush E, Balabolkin I, Bulgakova V, Novikova N, Zastelo E. et al. Characteristics of drug allergic reactions in children. Allergy. 2018; 73(S105):810.
Schnyder B. Approach to the patient with drug allergy. Immunol Allergy Clin North Am. 2009;29(3):405-18.
Demoly P., Adkinson N.F., Brockow K., Castells M., Chiriac A.M., Greenberger P.A. et al. International Consensus on drug allergy. Allergy. 2014;69(4):420-37.
Pirmohamed M., Ostrov D.A., Park B.K. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity. J Allergy Clin Immunol. 2015; 136(2): 236-44.
Ishida, Y. Kano, Y. Mizukawa, Shiohara, T. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome. Allergy. 2014;69(6):798-805.
Oussalah A, Mayorga C, Blanca M, Barbaud A, Nakonechna A, Cernadas J. et al. Task force ‘Genetic predictors of drug hypersensitivity’ of the European Network on Drug Allergy (ENDA) of EAACI. Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review. Allergy. 2016;71(4):443-62.
Faulkner L., Meng X., Park B.K., Naisbitt D.J. The importance of hapten-protein complex formation in the development of drug allergy. Curr Opin Allergy Clin Immunol. 2014;14(4):293-300.
Balabolkin I.I., Bulgakova V.A. Clinical allergology of childhood with urgent conditions [Klinicheskaya allergologiya detskogo vozrasta s neotlozhnymi sostoyaniyami]. Moscow; MIA; 2011.
Smirnova G.I. Diagnosis and modern methods of treatment of allergodermatosis in children. Rossiyskiy pediatricheskiy zhurnal. 2002; 3: 40-4. (in Russian)
Mayorga C., Brockow K., Przybilla B., Aberer W., Bircher A.J., Brehler R. et al. Guideline for the diagnosis of drug hypersensitivity reactions. Allergol J Int.2015;24(3):94-105.
Smirnova G.I. Severe forms of allergodermatosis in children: diagnosis and treatment. Rossiyskiy pediatricheskiy zhurnal. 2015;18(1):45-52.
Harr T, French LE. Stevens-Johnson syndrome and toxic epidermal necrolysis. Chem Immunol Allergy. 2012;97:149-66.
Schneider JA, Cohen PR. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Adv Ther. 2017;34(6):1235-44.
Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clin Rev Allergy Immunol. 2018;54(1):147-76.
Sato S, Kanbe T, Tamaki Z, Furuichi M, Uejima Y, Suganuma E et al. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatr Int. 2018;60(8):697-702.
Xiang Q, Gao X, Fang J, Pi L, Chen X, Chen L, Liu Q. Lacrimal passage irrigation in children with Stevens-Johnson syndrome or toxic epidermal necrolysis: a five-year retrospective study. BMC Ophthalmol. 2019;19(1):22. doi: 10.1186/s12886-018-1014-9.
Castellazzi ML, Esposito S, Claut LE, Daccò V, Colombo C. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis. Ital J Pediatr. 2018;44(1):93. doi: 10.1186/s13052-018-0535-4.
Lee VY, Booy R, Skinner SR, Fong J, Edwards KM. The effect of exercise on local and systemic adverse reactions after vaccinations -- Outcomes of two randomized controlled trials. Vaccine. 2018;36(46):6995-7002.
Torres MJ, Adkinson NF Jr, Caubet JC, Khan DA, Kidon MI, Mendelson L. et al. Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing. J Allergy Clin Immunol Pract. 2019;7(1):40-5.
Pratico AD, Longo L, Mansueto S, Gozzo L, Barberi I, Tiralongo V.et al. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study. Curr Drug Saf. 2018;13(3):200-7.
Lucas M, Arnold A, Sommerfield A, Trevenen M, Braconnier L, Schilling A. et al. Antibiotic Allergy Labels in Children Are Associated with Adverse Clinical Outcomes. J Allergy Clin Immunol Pract. 2018. doi: 10.1016/j.jaip.2018.09.003.
Friedmann PS, Ardern-Jones M. Patch testing in drug allergy. Curr Opin Allergy Clin Immunol. 2010;10(4):291-6.
Aberer W, Kränke B. Provocation tests in drug hypersensitivity. Immunol Allergy Clin North Am.2009;29(3):567-84.
Chiriac AM., Demoly P. Drug provocation tests: up-date and novel approaches. Allergy Asthma Clin Immunol. 2013;9(1):12.
Rerkpattanapipat T., Chiriac A.M., Demoly P. Drug provocation tests in hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol.2011;11(4):299-304.
Frumin J, Gallagher JC. Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances? Ann Pharmacother. 2009;43(2):304-15.
van Dijk SM, Gardarsdottir H, Wassenberg MW, Oosterheert JJ, de Groot,MC, Rockmann H The high impact of penicillin allergy registration in hospitalized patients. J Allergy Clin Immunol Pract 2016; 49(6):926-31.
Ibáñez MD, Rodríguez Del Río P, Lasa EM, Joral A, Ruiz-Hornillos J, Muñoz C. et al. Prospective assessment of diagnostic tests for pediatric penicillin allergy: From clinical history to challenge tests. Ann Allergy Asthma Immunol. 2018;121(2):235-44.
Dickson SD, Salazar KC. Diagnosis and management of immediate hypersensitivity reactions to cephalosporins. Clin Rev Allergy Immunol. 2013;45(1):131-42.
Shakouri AA, Bahna SL. Hypersensitivity to antihistamines. Allergy Asthma Proc. 2013;34(6):488-96.
Sanz ML, Gamboa PM, De Weck AL. Cellular tests in the diagnosis of drug hypersensitivity. Curr Pharm Des. 2008;14(5):2803-808.
Hausmann OV, Gentinetta T, Bridts CH, Ebo DG. The basophil activation test in immediate-type drug allergy. Immunol Allergy Clin North Am. 2009;29(4):555-66.
Martins IL, Nunes J, Charneira C, Morello J, Pereira SA, Telo JP. et al. The first-line antiepileptic drug carbamazepine: Reaction with biologically relevant free radicals. Free Radic Biol Med. 2018;129(5):559-68.
Fricke-Galindo I, LLerena A, Jung-Cook H, López-López M. Carbamazepine adverse drug reactions. Expert Rev Clin Pharmacol. 2018;11(7):705-18.
Wohrl S. NSAID hypersensitivity - recommendations for diagnostic work up and patient management. Allergol J Int. 2018;27(4): 114-21.
Cho YT, Chu CY. Treatments for Severe Cutaneous Adverse Reactions. J Immunol Res. 2017; 2017:1503709. doi: 10.1155/2017/1503709.
Elzagallaai AA, Greff M, Rieder MJ. Adverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics. Clin Pharmacol Ther. 2017;101(6):725-35.
Carr DF, Pirmohamed M. Biomarkers of adverse drug reactions. Exp Biol Med (Maywood). 2018;243(3):291-9.
Simons F.E., Ardusso L.R., Bilò M.B., Cardona V., Ebisawa M., El-Gamal Y.M. et al. International consensus on(ICON) anaphylaxis. World Allergy Organ J. 2014;7(1):9. doi: http://dx.doi.org/10.1186/1939-4551-7-9.
Egunsola O, Star K, Juhlin K, Kardaun SH, Choonara I, Sammons HM. Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database. BMJ Paediatr Open. 2017;1(1): e000039. doi: 10.1136/bmjpo-2017-000039.
Yang SC, Hu S, Zhang SZ, Huang JW, Zhang J, Ji C, Cheng B. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China. J Immunol Res. 2018; 2018: 4320195. doi: 10.1155/2018/4320195.
Gavigan GM, Kanigsberg ND, Ramien ML. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept. J Cutan Med Surg. 2018;22(5):514-5.
Mori F, Cianferoni A, Barni S, Pucci N, Rossi ME, Novembre E. Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions. J Allergy Clin Immunol Pract. 2015;3(3):375-80.
Norton AE, Konvinse K, Phillips EJ, Broyles AD. Antibiotic Allergy in Pediatrics. Pediatrics. 2018;141(5). doi: 10.1542/peds.2017-497.
Anterasian CM, Geng B. Penicillin skin testing in the management of penicillin allergy in an outpatient pediatric population. Allergy Asthma Proc. 2018;39(4):305-10.
Eaddy Norton A, Broyles AD. Drug allergy in children and adults: Is it the double X chromosome? Ann Allergy Asthma Immunol. 2019;122(2):148-55.